Anil Fastenau
Biographic Data
| ID | 7826274 |
|---|---|
| NAME | Anil Fastenau |
| GIVEN NAMES | Anil |
| FAMILY NAME | Fastenau |
| SIGNATURE | FASTENAU A |
| AFFILIATIONS | University of Bremen |
| ORCID | 0009-0009-8495-8227 |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 7 |
| WORKS AS EDITOR | 1 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Bridging the gap between health insurance eligibility and uptake
Publicly-funded health insurance schemes, wherein governments subsidize insurance contributions for disadvantaged groups, are a key strategy under universal health coverage. India’s Pradhan Mantri Jan Arogya Yojana (PM-JAY) uses an entitlement-based approach whereby approximately 700 million beneficiaries are automatically eligible for scheme benefits, subject to a simplified identity verification procedure instead of enrolment. This study invest…
Barriers to birth preparedness and complication readiness in Tanzania
Delayed diagnosis as a barrier to Zero Leprosy
Despite progress in leprosy control, delayed diagnosis remains a barrier to achieving Zero Leprosy, particularly in low-endemic settings. Diagnostic delay not only sustains hidden transmission but also leads to preventable disability and lifelong consequences for affected individuals. Pakistan, although classified as low endemic, continues to report a high proportion of new leprosy cases presenting with grade 2 disability (G2D), indicating delays…
Exploring the experiences of leprosy stigma among patients and healthcare workers in Norte de Santander, Colombia
This study examines leprosy-related stigma among patients and healthcare professionals in Colombia. Leprosy, classified as a WHO-listed NTD, is a chronic nerve disease causing sensory loss, disabilities, and deformities when untreated. This contributes to stigma, reducing quality of life, healthcare access, and income. Despite Colombia achieving WHO’s prevalence goal, some regions still face high detection rates. As a result, leprosy remains a ch…
Barriers to seeking healthcare services and contributing factors to grade 2 disability among women affected by leprosy in Telangana, India – a qualitative study
Leprosy, a neglected tropical disease, remains a significant global health issue, with India accounting for nearly 60% of cases in 2022. Untreated Leprosy can result in irreversible disabilities and lead to social stigma, significantly affecting the lives of patients and their families. This study explores the barriers faced by women with leprosy in accessing healthcare and other factors that contributed to the development of Grade 2 disability i…
Stigmatization and discrimination of female tuberculosis patients in Kyrgyzstan – a phenomenological study
and Conclusion. In contrast to previous research, this study did not find diagnostic delay nor non-adherence to treatment because of stigmatization and discrimination. However, experiences within the healthcare facilities impacted the perceived quality of care. Stigmatization within the family, mostly by in-laws, was anchored in the patriarchal and conservative attitudes of Kyrgyz society. Overall, key findings of this study were widespread lack …
Interventions to reduce leprosy related stigma
Stigmatisation is a major issue faced by those affected by leprosy globally. Reducing stigmatisation encourages care seeking behaviour to occur earlier and can help reduce harm and spread of leprosy. This systematic literature review aimed to summarise what effective stigma reducing interventions exist for leprosy, and as a secondary question explore what evidence exists regarding their cost. A systematic literature review was conducted. Three da…
Scrutinising delay in leprosy diagnosis in Colombia
Leprosy is an infectious neglected tropical disease, which can cause irreversible disabilities if not diagnosed in time. Colombia continues to show high rates of leprosy-related disability, mainly due to a delay in diagnosis. Limited knowledge is available that explains this delay, therefore our study aimed to explore the perceptions and experiences of leprosy health professionals with the delay in leprosy diagnosis in the Cesar and Valle del Cau…
No prominent works on this page.
Interventions to reduce leprosy related stigma
Stigmatisation is a major issue faced by those affected by leprosy globally. Reducing stigmatisation encourages care seeking behaviour to occur earlier and can help reduce harm and spread of leprosy. This systematic literature review aimed to summarise what effective stigma reducing interventions exist for leprosy, and as a secondary question explore what evidence exists regarding their cost. A systematic literature review was conducted. Three da…
Scrutinising delay in leprosy diagnosis in Colombia
Leprosy is an infectious neglected tropical disease, which can cause irreversible disabilities if not diagnosed in time. Colombia continues to show high rates of leprosy-related disability, mainly due to a delay in diagnosis. Limited knowledge is available that explains this delay, therefore our study aimed to explore the perceptions and experiences of leprosy health professionals with the delay in leprosy diagnosis in the Cesar and Valle del Cau…
Exploring the experiences of leprosy stigma among patients and healthcare workers in Norte de Santander, Colombia
This study examines leprosy-related stigma among patients and healthcare professionals in Colombia. Leprosy, classified as a WHO-listed NTD, is a chronic nerve disease causing sensory loss, disabilities, and deformities when untreated. This contributes to stigma, reducing quality of life, healthcare access, and income. Despite Colombia achieving WHO’s prevalence goal, some regions still face high detection rates. As a result, leprosy remains a ch…
Barriers to seeking healthcare services and contributing factors to grade 2 disability among women affected by leprosy in Telangana, India – a qualitative study
Leprosy, a neglected tropical disease, remains a significant global health issue, with India accounting for nearly 60% of cases in 2022. Untreated Leprosy can result in irreversible disabilities and lead to social stigma, significantly affecting the lives of patients and their families. This study explores the barriers faced by women with leprosy in accessing healthcare and other factors that contributed to the development of Grade 2 disability i…
Stigmatization and discrimination of female tuberculosis patients in Kyrgyzstan – a phenomenological study
and Conclusion. In contrast to previous research, this study did not find diagnostic delay nor non-adherence to treatment because of stigmatization and discrimination. However, experiences within the healthcare facilities impacted the perceived quality of care. Stigmatization within the family, mostly by in-laws, was anchored in the patriarchal and conservative attitudes of Kyrgyz society. Overall, key findings of this study were widespread lack …
Bridging the gap between health insurance eligibility and uptake
Publicly-funded health insurance schemes, wherein governments subsidize insurance contributions for disadvantaged groups, are a key strategy under universal health coverage. India’s Pradhan Mantri Jan Arogya Yojana (PM-JAY) uses an entitlement-based approach whereby approximately 700 million beneficiaries are automatically eligible for scheme benefits, subject to a simplified identity verification procedure instead of enrolment. This study invest…
Barriers to birth preparedness and complication readiness in Tanzania
Delayed diagnosis as a barrier to Zero Leprosy
Despite progress in leprosy control, delayed diagnosis remains a barrier to achieving Zero Leprosy, particularly in low-endemic settings. Diagnostic delay not only sustains hidden transmission but also leads to preventable disability and lifelong consequences for affected individuals. Pakistan, although classified as low endemic, continues to report a high proportion of new leprosy cases presenting with grade 2 disability (G2D), indicating delays…
Health care (4 works) · Tuberculosis Research and Epidemiology (4 works) · Family medicine (3 works) · Leprosy (3 works) · Leprosy Research and Treatment (3 works) · Medicine (3 works) · Psychology (3 works) · Public health (3 works) · Disease (2 works) · Environmental health (2 works)